05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Dietary supplements for animals; medicated feed additives
for animals; medicated supplements for foodstuffs for
animals; feed supplements for veterinary use; feeding
stimulants for animals; medicated animal feed; medicated
additives for animal foods; probiotic supplements for
animals; enzymes for veterinary purposes; enzyme dietary
supplements for animals; amino acids for veterinary
purposes; protein supplements for animals; bacterial
preparations for veterinary purposes; herbal detoxification
agents for animals; mineral dietary supplements for animals;
nutritional supplements for livestock feed; food supplements
for farm animals; nutritional supplements for veterinary
use. Animal foodstuffs; mixed animal feed; formula animal feed;
animal feed preparations; yeast for animal fodder.
The disclosure relates to the field of food ingredients, specifically to sweeteners, more specifically to steviol glycosides and improved isolation thereof.
The present invention relates to cosmetic compositions containing an alkandiol and one or more cosmetic oils, characterized in that at least one of the cosmetic oils is isoamyl caprylate caprate. Said compositions exhibit an improved water repellency (lotus effect) and sensory attributes.
Disclosed herein are implants, methods of forming implants, and formulations comprising implants. The implants comprise a biodegradable polymer, a biotherapeutic, and vitamin E. The biodegradable polymer is a polyesteramide (PEA) of defined structure. The implant may be highly loaded with biotherapeutic and may exhibit desirable release properties in vivo.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
The present invention relates to a process degumming and refining crude Brassica carinata oils and feedstocks comprising such crude oils. The process comprises a step of incubating the feedstocks with a fungal phospholipase A1 having at least 50%, more preferably at least 75%, sequence identity with SEQ ID NO: 1. The process can further comprise incubating the feedstocks with a fungal phospholipase A1 in the presence of an acid, separating the phosphorous-containing components from the processed feedstock, e.g. by centrifugation, and/or an adsorption step using e.g. bleaching earth. The invention further relates to feedstocks comprising B. carinata oil or B. carinata oils that have been degummed using the process of the invention, as well as the use of a fungal phospholipase A1 for degumming and/or refining of crude B. carinata oils and feedstocks comprising such crude oils.
Disclosed herein are particles, methods of forming particles, and formulations comprising particles. The particles are particles comprising a biodegradable polymer and a biotherapeutic at specified loading. The biodegradable polymer is a polyesteramide (PEA) of defined structure. The particles may exhibit desirable release properties in vivo.
The present invention relates to a method for improved demineralization of fermentation broths, including the steps of providing a solution comprising one or more oligosaccharides, carrying out a first membrane filtration and preferably being a microfiltration or ultrafiltration, a second membrane filtration of the permeate of the first membrane filtration and a first nanofiltration step; with a sub-step of concentration and/or a sub-step of diafiltration. Moreover, the present invention is directed to an improved purification of fine chemicals from a fermentation broth.
C07H 1/08 - SeparationPurification from natural products
A23C 9/142 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
A23C 9/146 - Milk preparationsMilk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
C07H 3/06 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
10.
GLUCOAMYLASE AS BINDING AGENT FOR NON-ANIMAL PROTEIN FOOD PRODUCTS
The present invention relates to the field of food. Herein disclosed is a method for preparing a non-animal protein food product or a cultured meat food product comprising adding a thermolabile glucoamylase protein preparation to an ingredient used in the preparation of said food product and processing the obtained glucoamylase protein preparation and ingredient composition into a non-animal protein food product or a cultured meat food product.
A23J 3/34 - Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
A23J 3/22 - Working-up of proteins for foodstuffs by texturising
A23L 29/269 - Foods or foodstuffs containing additivesPreparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of:
a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out in the presence of acetate or a acetate salt;
b) applying shear to the fermentation broth and optionally concentrating the fermentation broth.
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of:
a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out in the presence of acetate or a acetate salt;
b) applying shear to the fermentation broth and optionally concentrating the fermentation broth.
Compositions so obtained and use of such compositions.
The present invention relates to a method for fermenting carbohydrate comprising a compound having formula (I), a use of said compound compound for improving growth, uptake, metabolization and/or fermentation of carbohydrate by a yeast, and for increasing ethanol production of a yeast.
C12N 1/38 - Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factorsStimulation of growth by removal of a chemical compound
C12P 7/10 - Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate substrate containing cellulosic material
The invention relates to the field of fermentation technology. The invention specifically relates to genes that are useful for protecting bacterial strains from phage infections, and to bacterial strains comprising such genes. Such strains can be used in methods to produce a fermented food product such as a fermented milk product. The invention also relates to food products produced using such strain or composition.
C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
C12Q 1/04 - Determining presence or kind of microorganismUse of selective media for testing antibiotics or bacteriocidesCompositions containing a chemical indicator therefor
C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving nucleic acids
The present invention relates to a new formulation comprising a high amount of at least one cannabinoid, wherein the cannabinoid is in a non-crystalline form.
The present invention relates to sunscreen compositions containing bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) and one or more cosmetic oils, characterized in that at least one of the cosmetic oils is isoamyl caprylate caprate. Said compositions exhibit an improved water repellency (lotus effect) and sensory attributes.
The present invention relates to a method for fermenting a carbohydrate and/or for producing ethanol, comprising a fumonisin esterase polypeptide, and a use thereof for improving yeast growth, carbohydrate uptake and/or ethanol production.
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and which is capable of hydrolysing non-phosphorylated sucrose into fructose and glucose.
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and which is capable of hydrolysing non-phosphorylated sucrose into fructose and glucose.
The identification of efficient enzymes capable of hydrolysing sucrose in its non-modified form, and which on its own enable the cell to utilize sucrose as a, or as the main and/or sole, carbon and/or energy source, i.e., without the need for multi-gene sucrose utilizing systems comprising several other heterologous polypeptides, such as other enzymes and/or transporters, is highly advantageous, since it allows for cost-effective use of sucrose in large scale production processes.
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of:
a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out at a temperature of equal to or less than 39° C., preferably equal to or less than 37° C. and at a pH setpoint of equal to or less than 5.6, preferably equal to or less than 5.4;
b) applying shear to the fermentation broth and optionally concentrating the fermentation broth.
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of:
a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out at a temperature of equal to or less than 39° C., preferably equal to or less than 37° C. and at a pH setpoint of equal to or less than 5.6, preferably equal to or less than 5.4;
b) applying shear to the fermentation broth and optionally concentrating the fermentation broth.
Compositions so obtained and use of such compositions.
The present invention relates to a combination comprising vitamin C and Lactobacillus rhamnosus and its use for improving gut health in animals and humans. It was found that a combination of vitamin C and Lactobacillus rhamnosus, when delivered to the large intestine, increases the concentration of butyrate in the intestinal tract.
The present invention relates to a combination comprising vitamin C and Bifidobacterium animalis ssp. lactis and its use for improving gut health in animals and humans. It was found that a combination of vitamin C and Bifidobacterium animalis ssp. lactis, when delivered to the large intestine, increases the concentration of SCFAs, including butyrate, in the intestinal tract.
The present invention relates to the production of sialylated Human Milk Oligosaccharides (HMOs), in particular to the production of sialyl-lacto-N-neotetraose (LST-c), from precursor oligosaccharides and the genetic engineering of suitable cells for use in said production, as well as to methods for producing said sialylated HMOs.
C12N 15/52 - Genes encoding for enzymes or proenzymes
C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
26.
NEW FUCOSYLTRANSFERASES FOR IN VIVO SYNTHESIS OF LNFP-III
The present disclosure relates to the production of fucosylated Human Milk Oligosaccharides (HMOs). In particular, it relates to alpha-1,3-fucosyltransferases for the production of lacto-N-fucopentaose III (LNFP-III), as well as to genetically engineered cells and their use in said production. Preferably the alpha-1,3-fucosyltransferases described herein do not fucosylate the reducing end of the acceptor oligosaccharide used as substrate for the alpha-1,3-fucosyltransferases.
The present disclosure relates to a method of increasing nicotinamide mononucleotide (NMN) and/or nicotinamide adenine dinucleotide (NAD+) in the gut of a subject by administering a combination comprising at least one Bifidobacterium sp. capable of growing on a sialylated HMO and having a functional de novo nicotinamide adenine dinucleotide (nad) operon (nadC, nadD and nadE) and at least one fucosylated oligosaccharide to said subject.
A61K 8/99 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
A61P 39/06 - Free radical scavengers or antioxidants
Joint spacers are disclosed. In an embodiment, a joint spacer comprises a foam (1), a first articular surface (3) and a second articular surface (4). The foam has a first porosity at a first location and a second porosity, less than the first porosity, at a second location. In an embodiment, the first porosity is more proximate a first external surface (5) of the joint spacer and the second location is more proximate a second external surface (6) of the joint spacer.
The present invention relates to the production of fucosylated Human Milk Oligosaccharides (HMOs), and in particular to the production of complex fucosylated HMOs with five or more monosaccharide units, such as LNFP-V and LNDFH-II, from precursor oligosaccharides and the genetic engineering cells and α-1,3(4)-fucosyltransferases suitable for use in said production of suitable for use in said production, as well as to methods for producing said fucosylated HMOs.
C12P 19/04 - Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
30.
NOVEL PROCESS FOR PRODUCING A FERMENTED MILK PRODUCT AND NEW FERMENTED MILK PRODUCT SO PRODUCED
The invention provides a process for the production of a fermented milk product, preferably a yogurt, comprising the steps of:
(a) fermenting the milk-base with one or more lactic acid bacterial strains, a coagulant and a stabilizer to generate a fermented milk product; and
(b) heat treating the fermented milk product at a temperature of at least 70° C. for a period of at least 5 seconds to generate a heat-treated fermented milk product.
The invention provides a process for the production of a fermented milk product, preferably a yogurt, comprising the steps of:
(a) fermenting the milk-base with one or more lactic acid bacterial strains, a coagulant and a stabilizer to generate a fermented milk product; and
(b) heat treating the fermented milk product at a temperature of at least 70° C. for a period of at least 5 seconds to generate a heat-treated fermented milk product.
Preferably the heat-treated fermented milk product is subsequently stored in a step (c) at a temperature in the range from equal to or more than 10° C. to equal to or less than 40° C.
A23C 9/12 - Fermented milk preparationsTreatment using microorganisms or enzymes
A23B 11/13 - Preservation of milk or milk preparations by heating the materials being loose unpacked
A23C 9/123 - Fermented milk preparationsTreatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceaeYoghurt
A23C 9/127 - Fermented milk preparationsTreatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
A23C 9/13 - Fermented milk preparationsTreatment using microorganisms or enzymes using additives
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of:
a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out in the presence of calcium or a calcium salt;
b) applying shear to the fermentation broth and optionally concentrating the fermentation broth.
A process for the production of a Lactobacillus rhamnosus, wherein the process comprises the steps of:
a) fermenting the Lactobacillus rhamnosus in a lactose-free, preferably milk-free, medium in a fermentor, and removing a fermentation broth from the fermentor, wherein the fermentation is carried out in the presence of calcium or a calcium salt;
b) applying shear to the fermentation broth and optionally concentrating the fermentation broth.
Compositions so obtained and use of such compositions.
The present invention relates to the production of fucosylated Human Milk Oligosaccharides (HMOs), and in particular to the production of complex fucosylated HMOs with five or more monosaccharide units such as LNFP-II, LNFP-III and LNDFH-I from precursor oligosaccharides and the genetic engineering of suitable cells for use in said production, as well as to methods for producing said fucosylated HMOs.
An oil comprising (i) at least 30 wt. % of one or more polyunsaturated fatty acids having at least 4 double bonds; (ii) at least one first antioxidant; and (iii) less than about 1000 ppm lecithin. The oil may comprise less than about 750 ppm of a second antioxidant chosen from an ascorbic acid derivative.
The present invention relates to an isolated polypeptide, or a functional fragment thereof, having at least 85% sequence identity to SEQ ID NO: 12, comprising an amino acid substitution at position C113, preferably C113A.
The present invention relates to an antimicrobial oligomer and to an antimicrobial coating composition comprising said antimicrobial oligomer. The present invention also relates to a medical device comprising the antimicrobial coating composition and to a method for coating said coating composition on a medical device.
C08G 18/24 - Catalysts containing metal compounds of tin
C08G 18/28 - Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Biological preparations for industrial and scientific purposes; biological and biochemical preparations for use in the field of biopharma; biological and biochemical preparations for use in the manufacture of biopharmaceutical products; chemical preparations for use in the manufacture of biopharmaceutical products.
The present invention relates to a new formulation, which is a gummy product comprising a high amount of at least one oily ingredient. The gummy product includes an oily ingredient can be any oil/fat. Suitable oils/fats are i.e. any PUFA, a fat-soluble vitamin, any carotenoid, any cannabinoid oil. The disclosed invention also includes a process for producing said gummy product.
A23G 3/36 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition
A23G 3/40 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition characterised by the fats used
A23G 3/42 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition characterised by the carbohydrates used, e.g. polysaccharides
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/00 - Medicinal preparations containing organic active ingredients
A61K 31/202 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid having three or more double bonds, e.g. linolenic acid
A61K 47/36 - PolysaccharidesDerivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K 47/46 - Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
40.
IMPROVING LAYER BIRD PERFORMANCE USING AN OLIGOSACCHARIDE PREPARATION
The present invention relates to a method for improving performance of a layer bird by administering a nutritional composition comprising an oligosaccharide preparation to the layer bird, and to a use of an oligosaccharide preparation to improve performance of a layer bird.
A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
The invention provides composite materials that form a biocompatible and bioresorbable settable ceramic-forming composition, and that possesses high strength when set and other desirable mechanical properties. The composite materials may include additive materials that provide beneficial advantages in the handling and physical properties of the material. When a hydrated precursor, the composite material is capable of being injected through cannulas for placement in treatment sites. The composite material provides desirable handling properties and sets in a clinically relevant time period.
A61L 27/46 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
The present invention relates to a process of manufacturing 2,3,5-tri-methylhydroquinone from a mixture of mesitol and 2,3,6-trimethylphenol (=2,3,6-TMP). This process offers a highly interesting and commercial interesting way of producing α-tocopherol.
C07C 37/01 - Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
The method (900) for predicting Eimeria maxima infection or prevalence in animals comprises the steps of: - providing (905) a plurality of features and a plurality of empirically measured biomarker data; - training (910), using as input the plurality of features and historical biomarker data, a machine learning model to associate predetermined labels indicating whether the set of animals have Eimeria maxima infection or prevalence to said input; - receiving (915), measured biomarker data corresponding to one or more animals, wherein the measured biomarker data indicates blood concentrations of one or more biomarkers in the one or more animals; providing (920), the biomarker data as input to the trained machine learning model; receiving (925) at least one predetermined label indicating whether the one or more animals are positive for Eimeria maxima infection or prevalence or susceptible to mMX prevalence; and providing (930), upon a computer interface, at least one predetermined label received.
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
G01N 33/569 - ImmunoassayBiospecific binding assayMaterials therefor for microorganisms, e.g. protozoa, bacteria, viruses
Method (900) for predicting of Eimeria acervuline (GAC) infection or GAC prevalence in animals, characterized in that it comprises the steps of: receiving (905), by a computing system, biomarker data corresponding to one or more animals, wherein the biomarker data indicates blood concentrations of one or more biomarkers in the one or more animals, providing (910), by the computing system, as input to a trained machine learning model, the biomarker data, wherein a machine learning model is trained based on training data comprising a plurality of features, historical biomarker data associated with a set of animals, and predetermined labels indicating whether the set of animals have the GAC infection or GAC prevalence, receiving (915), by the computing system, as output from the trained machine learning model, at least one health indicator representative of whether the one or more animals are positive for the GAC infection or susceptible to GAC prevalence or indicating the extent of the GAC infection or GAC prevalence in the one or more animals, and providing (920), upon a computer interface, at least one health indicator received.
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
The present invention is related to a process for transformation of low activity enzymes involved in acetylation of retinoids into high activity enzymes, particular high activity towards acetylation of retinol into retinyl acetate.
The present invention relates to a combination comprising vitamin B2 and Lactobacillus rhamnosus and its use for improving gut health in animals and humans. It was found that a combination of vitamin B2 and Lactobacillus rhamnosus, when delivered to the large intestine, increases the abundance of beneficial Bifidobacteriaceae and Bifidobacterium bacteria in the intestinal tract.
A61K 35/747 - Lactobacilli, e.g. L. acidophilus or L. brevis
A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
A61K 35/00 - Medicinal preparations containing materials or reaction products thereof with undetermined constitution
A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
09 - Scientific and electric apparatus and instruments
35 - Advertising and business services
36 - Financial, insurance and real estate services
41 - Education, entertainment, sporting and cultural services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
45 - Legal and security services; personal services for individuals.
Goods & Services
(1) Downloadable or recorded application software for analyzing data; downloadable or recorded computer software for database management; downloadable or recorded computer software for creating searchable databases of information and data; downloadable computer software for remote monitoring and analysis; software for the analysis of business data; intelligent gateways for real-time data analysis; customer relation management software; all in the field of agriculture, aquaculture, animal feed, farm management and animal breeding. (1) Digital advertising services; marketing services provided by means of digital networks; retail and wholesale of recorded computer programs; commercial or administrative management and accounting services for agriculture, aquaculture, animal feed, farm management and animal breeding; business analysis; cost analysis; economic forecasting analysis for business purposes; business production analysis for agriculture, aquaculture, animal feed, farm management and animal breeding.
(2) Financial analysis and consultation; preparation and analysis of financial reports; financial data analysis all in the field of agriculture, aquaculture, animal feed, farm management and animal breeding.
(3) Education and providing of training in the field of agriculture, aquaculture, animal feed, farm management and animal breeding.
(4) Providing scientific information, advice and consultancy and scientific research services in the field of agriculture, aquaculture, animal feed, farm management and animal breeding; providing temporary use of on-line non-downloadable software for creating searchable databases of information and data; software as a service; hosting of databases; technical services for the downloading of digital data; computer program development; computer software rental; computer software upgrade; computer program duplication; technical design studies; computer software installation; computer system design; technological analysis services in the field of data processing, engineering and technological planning services in the field of information and communications networks and information technology; computer programming services for commercial analysis and reporting.
(5) Providing consultation services in the field of agriculture, aquaculture, animal feed, farm management and animal breeding; providing advice, information and consultancy in the field of animal management and sustainability in animal farming, agriculture and in livestock farming and aquatic farming; agricultural services relating to herd management, optimal animal nutrition, animal welfare, optimal farming performance.
(6) Online social networking services relating to agriculture, aquaculture, animal feed, farm management and animal breeding.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
Goods & Services
Glass-ceramic materials for industrial use; silicate-based
bioactive glass and glass-ceramic compositions for use in
manufacturing, research, and development of biomaterials. Biological bone implant materials; medicinal preparations
containing inorganic active ingredients. Bioactive glass ceramic for medical use; medical implants,
prosthetic devices, and surgical instruments incorporating
bioactive glass and glass-ceramic materials; bioactive glass
and glass-ceramic materials for use in bone regeneration and
tissue engineering; biocompatible glass-ceramic powders,
granules, and scaffolds for surgical implants.
Some aspects of the disclosure relate to processes for preparing liquid dispersions, which may comprise directing a pre-dispersion with a liquid and an oily phase through one or more filtration elements (104), and/or filtering an aqueous solution of the hydrocolloids before preparation of the pre-dispersion, and pumping the pre-dispersion into a turbulence chamber (102) and ejecting a liquid dispersion from the turbulence chamber (102) with the dispersed liquid phase having an average size of 50-220 nm, where the residence time of the pre-dispersion in the turbulence chamber (102) for each of the one or more passes through the turbulence chamber (102) is less than 10−6 seconds.
B01F 25/51 - Circulation mixers, e.g. wherein at least part of the mixture is discharged from and reintroduced into a receptacle in which the mixture is circulated through a set of tubes, e.g. with gradual introduction of a component into the circulating flow
The present disclosure relates to the biosynthetic production of the fucosylated Human Milk Oligosaccharides (HMO), 3-fucosyllactose, as well as to genetic engineering cells and α-1,3-fucosyltransferases suitable for use in said biosynthetic production, as well as to methods for producing 3FL.
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
The present invention is related to production of retinyl acetate generated via enzymatic conversion of retinol, said process including the use of modified enzymes with improved activity.
The present invention is related to increased accumulation of carotenoids and derivatives thereof via manipulation and heterologous expression of CarRP derived from Mucor circinelloides.
C12P 23/00 - Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
55.
COMPOSITIONS COMPRISING EPILOBIUM FLEISCHERI EXTRACT FOR TREATING SIGNS OF AGING
The present invention relates to the mandelic acid addition salt of palmitoyl lysylvalyl-lysine as well as to cosmetic preparation comprising said salt. Furthermore, the invention relates to a to the use of mandelic acid to prepare the mandelic acid addition salt of palmitoyl lysylvalyl-lysine to increase the storage stability of palmitoyl lysylvalyl-lysine.
C07K 5/09 - Tripeptides the side chain of the first amino acid containing more amino groups than carboxyl groups, or derivatives thereof, e.g. Lys, Arg
A61K 8/64 - ProteinsPeptidesDerivatives or degradation products thereof
C07C 1/34 - Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from compounds containing hetero atoms other than, or in addition to, oxygen or halogen reacting phosphines with aldehydes or ketones, e.g. Wittig reaction
C07C 403/24 - Derivatives of cyclohexane or of a cyclohexene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
58.
POLYESTERAMIDE COPOLYMERS POSSESSING HIGH GLASS TRANSITION TEMPERATURES
Disclosed herein are polyesteramide random copolymers having high glass transition temperatures, methods of forming such polymers, devices, formulations, and medical devices containing such polymers, and methods of treating mammals suffering from various conditions using such polymers in combination with a bioactive agent. In an embodiment, the random copolymers may have a Tg above body temperature, about 37° C., and may achieve a longer release duration, different release kinetics, improved barrier properties, or other benefits over polymers with Tg below 37° C.
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/5575 - Eicosanoids, e.g. leukotrienes having a cyclopentane ring, e.g. prostaglandin E2, prostaglandin F2-alpha
A61K 47/34 - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
The present invention provides a novel process for producing panthenol from pantothenic acid or salts and/or esters thereof. The process makes a “hybrid process” possible to produce panthenol, which is generally more eco-friendly and sustainable and reduces carbon print compared to a pure chemical process.
C07C 231/12 - Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
C07C 235/08 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
The present invention relates to a new formulation, which is a gelled confection, which comprises a high amount (concentration) of at least one PUFA. In an embodiment, a gelled confection comprises encapsulated particles comprising a coacervate shell encapsulating at least one PUFA, at least one gelling substance, and water, wherein the content of the at least one PUFA is at least 10 mg/g of the gelled confection.
A23G 3/40 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition characterised by the fats used
A23D 7/005 - Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
A23G 3/36 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition
A23G 3/42 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition characterised by the carbohydrates used, e.g. polysaccharides
A23G 3/48 - Sweetmeats, confectionery or marzipanProcesses for the preparation thereof characterised by the composition containing plants or parts thereof, e.g. fruits, seeds, extracts
A23G 3/54 - Composite products, e.g. layered, coated, filled
The present invention relates to vitamin B2 (riboflavin) for use in improving gut health in animals and humans. In particular, it was found that vitamin B2, upon delivery to the large intestine, increases the abundance of the beneficial bacteria Lactobacillus rhamnosus in the intestinal tract.
The present invention relates to an improved process for preparing triphenylphosphine (TPP) by reacting triphenylphosphine oxide (TPPO) with a specific catalyst.
B01J 31/14 - Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides of aluminium or boron
The present disclosure relates to a genetically modified cell capable of producing UDP-N-acetylglucosamine (UDP-GlcNAc), wherein the mRNA stability of the native glucosamine-6-phopshate synthase (glmS) is enhanced by modifying said cell such that it has decreased or total loss of function of RNase adapter protein RapZ (yhbJ). In particular, the present disclosure relates to said cells that are likewise capable of producing one or more N-acetylated- and/or sialylated molecules, such as N-acetylated- and/or sialylated human milk oligosaccharides (HMOs). The present disclosure further relates to a method for producing one or more N-acetylated- and/or sialylated human milk oligosaccharides (HMO) making use of such cells.
The present disclosure relates to a method for producing one or more oligosaccharides by co-culturing two different oligosaccharide producing strains. The method is useful for producing a balanced mixture of oligosaccharides, a selected oligosaccharide with reduced by-product formation and complex oligosaccharides, in particular complex fucosylated and sialylated HMOs. The co-cultivation is controlled by controlling the carbon source the individual strains can grow on.
C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
C12P 19/14 - Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase, e.g. by alpha-amylase
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
01 - Chemical and biological materials for industrial, scientific and agricultural use
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
Goods & Services
Chemicals for use in the manufacture of cosmetics;
emollients used for the manufacture of cosmetic products. Cosmetic preparations, cosmetic preparations for skin care,
perfumery, essential oils.
Joint spacers are disclosed. In an embodiment, the joint spacers are biostable and have a first side (3) comprising a convex portion (5) and a peripheral portion (6) surrounding the convex portion. The convex portion comprises a foam (1) and the foam has a porosity in the peripheral portion that is less than the porosity at the thickest point of the convex portion.
A topical composition, preferably a skincare and/or haircare composition and/or a composition to treat, care for or improve the appearance of the skin and/or scalp, more preferably an anti-dandruff composition and/or anti-acne composition, wherein such composition comprises one or more Malassezia postbiotics and wherein the Malassezia postbiotics are derived from Malassezia species furfur. A topical composition, preferably a cosmetic skincare composition for non-therapeutic use,wherein such composition comprises one or more Malassezia postbiotics and wherein the Malassezia postbiotics are derived from Malassezia species restricta, Malassezia species globosa or a mixture thereof; and preferably wherein the composition does not comprise Malassezin. A process for the preparation of a cosmetic composition, comprising the steps of: - Lysis of one or more Malassezia microorganisms, wherein the one or more Malassezia microorganisms comprise a CCL5 inhibitor and/or a CCL27 inhibitor and/or an IVL stimulator, to yield Malassezia postbiotics; and - Combining the Malassezia postbiotics with a cosmetically acceptable carrier and optionally one or more human milk oligosaccharides.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Mixtures of chemicals and microorganisms for increasing the nutritional value of animal fodder other than for veterinary use; Acids for use in the preparation of animal foodstuffs; Surfactants for the production of animal feed; Antioxidants for use in manufacturing processes for feed and feed supplements; Proteins for use in animal feed and feed supplement manufacturing processes; Vitamins for the production of feed and feed supplements; Antioxidants for the production of feed and feed supplements; Enzymes to assist in digestion for use in the manufacture of animal feeds; Enzymes for use in the manufacture of feed and feed supplements; Chemical additives for use in the preparation of animal foodstuffs; Chemical additives for use in the manufacture of animal foodstuffs. Dietary supplements for animals; Feed additives for animals; Medicated supplements for foodstuffs for animals; Feed supplements for veterinary use; Feeding stimulants for animals; Medicated animal feed; Medicated additives for animal foods; Probiotic supplements for animals; Enzymes for veterinary purposes; Enzyme dietary supplements for animals; Amino acids for veterinary purposes; Protein supplements for animals; Bacterial preparations for veterinary purposes; Herbal detoxification agents for animals; Mineral dietary supplements for animals; Nutritional supplements for livestock feed; Food supplements for farm animals; Nutritional supplements for veterinary use. Animal foodstuffs; Mixed animal feed; Formula animal feed; Animal feed preparations; Yeast for animal fodder.
69.
EICOSAPENTAENOIC ACID-PRODUCING MICROORGANISMS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF
The present invention is directed to isolated microorganisms as well as strains and mutants thereof, biomasses, microbial oils, compositions, and cultures; methods of producing the microbial oils, biomasses, and mutants; and methods of using the isolated microorganisms, biomasses, and microbial oils.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
10 - Medical apparatus and instruments
Goods & Services
glass-ceramic materials for industrial use; silicate-based bioactive glass and glass-ceramic compositions for use in manufacturing, research, and development of biomaterials biological bone implant materials; medicinal preparations containing inorganic active ingredients bioactive glass ceramic for medical use; medical implants, prosthetic devices, and surgical instruments incorporating bioactive glass and glass-ceramic materials; bioactive glass and glass-ceramic materials for use in bone regeneration and tissue engineering; biocompatible glass-ceramic powders, granules, and scaffolds for surgical implants
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to a combination of 3-nitrooxypropanol and/or derivatives thereof in the drinking water and to its administration to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to the field of reduction of methane emission in ruminants. Particularly, it relates to a combination of 3-nitrooxypropanol and/or derivatives thereof and Copper (II) sulphate with improved storage-stability and to its administration to a ruminant for reducing the production of methane emanating from the digestive activities of said ruminant.
The present invention relates to food products comprising recombinant polypeptide compositions that are substantially free of aspartyl protease-like activity. The invention also relates to compositions comprising recombinant milk polypeptides and that are substantially free of aspartyl protease-like activity; and methods and tools for manufacture of such compositions.
C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
A23C 11/08 - Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing caseinates but no other milk proteins nor milk fats
A23J 1/18 - Obtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from yeasts
This invention relates to a method for reducing total Ca and/or available P in poultry feed, a method for growing poultry, a method for selecting a desired food conversion rate for poultry, a method for producing poultry feed, use of hydroxylated vitamin D for obtaining in poultry essentially the same feed conversion rate, and poultry feed.
The method (100) to determine in real-time and display the skin condition of a user on at least one image of the user comprises the steps of: locally measuring (105) a value for said skin condition parameter for at least one site of an element of the body of the user, and, iteratively and in real-time: capturing (110) at least one image of the element of the body of the user, on a computing device, fitting (115) a virtual mesh with the element of the body of the user captured in the at least one image, on a computing device, interpolating (120) skin condition parameter values, on a computing device, superimposing (135) the fitted virtual mesh on at least one image captured, on a computing device, calculating (125) at least one local value for an image modification parameter as a function of the measured or interpolated skin condition parameter for at least one site, on a computing device, associating (140) the calculated at least one local value for an image modification parameter with coordinates of the fitted virtual mesh, at least one of the steps fitting, superimposing, interpolating, calculating or associating being performed on a graphic card of the computing device, and on a display device, displaying (130) the modified captured at least one image of the element of the body of the user.
A method, preferably a cosmetic and/or non-therapeutic method of - treating or preventing an inflammation of a keratinous tissue; and/or -reducing or inhibiting the activity of IL-1α protein, IL-8 protein and/or VEGF protein in a keratinous tissue; and/or - soothing, reducing, treating and/or preventing one or more symptoms of a sensitive skin, preferably chosen from the group consisting of skin redness, vascular hyper-reactivity, stinging, itching and burning; and /or - reducing transepidermal water loss (TEWL), wherein the method comprises a step of application to such keratinous tissue of a combination, which combination comprises or consists of a) Scutellaria extract; and b) Spent grain wax, preferably a mixture comprising spent grain wax, argan oil, and shea butter. A use and a composition useful in such method and use.
The present invention relates to emulsions containing at least one UVA sunscreen active agent and having improved sun protection factor (SPF) properties, as well as methods of improving sun protection factor (SPF) properties.
A61K 8/98 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution of animal origin
A61Q 17/04 - Topical preparations for affording protection against sunlight or other radiationTopical sun tanning preparations
79.
PROCESS FOR THE PRODUCTION OF A TRIAZINE DERIVATIVE
A61K 8/00 - Cosmetics or similar toiletry preparations
A61Q 17/00 - Barrier preparationsPreparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Dietary supplements for animals; feed additives for animals;
medicated supplements for foodstuffs for animals; feed
supplements for veterinary use; feeding stimulants for
animals; medicated animal feed; medicated additives for
animal foods; probiotic supplements for animals; enzymes for
veterinary purposes; enzyme dietary supplements for animals;
amino acids for veterinary purposes; protein supplements for
animals; bacterial preparations for veterinary purposes;
herbal detoxification agents for animals; mineral dietary
supplements for animals; nutritional supplements for
livestock feed; food supplements for farm animals;
nutritional supplements for veterinary use. Animal foodstuffs; mixed animal feed; formula animal feed;
animal feed preparations; yeast for animal fodder.
09 - Scientific and electric apparatus and instruments
42 - Scientific, technological and industrial services, research and design
Goods & Services
Downloadable software in the nature of a mobile application
for monitoring animal feed ingredients, monitoring animal
health, welfare and nutrition, and monitoring animal's
environmental impact, all in the field of animal management;
downloadable software for monitoring animal feed
ingredients, monitoring animal health, welfare and
nutrition, and monitoring animals' environmental impact, all
in the field of animal management. Providing use of on-line non-downloadable software for
monitoring animal feed ingredients, monitoring animal
health, welfare and nutrition, and monitoring animals'
environmental impact, all in the field of animal management.
82.
MICROBIAL OILS HAVING HIGH EPA CONTENT AND METHODS OF MAKING THE SAME
The present disclosure describes microbial oil compositions that can include a biomass present in a culture medium. The biomass can include a microbial oil enriched in EPA. The present disclosure also describes methods of producing microbial oils enriched in EPA. The present disclosure also describes nutritional oil compositions including the microbial oils and nutritional oil concentrates prepared from the nutritional oil compositions or microbial oils.
The invention relates to a method for producing a yogurt comprising galacto-oligosaccharide (GOS), wherein the method comprises the steps of (a) providing a milk base comprising lactose (b1) treating the milk base with Sporobolomyces singularis beta-hexosyltransferase or a variant thereof to generate GOS followed by fermenting the treated milk base with a lactic acid bacterial strain until a pH below is reached, or (b2) treating and fermenting the milk base at the same time by treating the milk base with Sporobolomyces singularis beta-hexosyltransferase or a variant thereof to generate GOS and by fermenting the milk base with a lactic acid bacterial strain until a pH below 5 is reached such as to produce a yogurt comprising GOS, and wherein said method does not comprise a step for inactivating the Sporobolomyces singularis beta-hexosyltransferase or a variant thereof.
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
A23C 9/12 - Fermented milk preparationsTreatment using microorganisms or enzymes
C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
84.
PROCESS FOR THE PRODUCTION OF C6-C18 ALKYL ESTERS OF 4-AMINOBENZOIC ACID
C07C 227/18 - Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
C07C 229/60 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
The present invention relates to the use of 25-hydroxy-vitamin D3 in animal breeding. More particularly, the invention relates to an injectable composition of 25-hydroxy- vitamin D3 and its use of 25-hydroxy-vitamin D3 raising plasma25-hydroxy-vitamin D3 levels of piglets in pig breeding.
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Dietary supplements for animals; medicated feed additives
for animals; medicated supplements for foodstuffs for
animals; feed supplements for veterinary use; feeding
stimulants for animals; medicated animal feed; medicated
additives for animal foods; probiotic supplements for
animals; enzymes for veterinary purposes; enzyme dietary
supplements for animals; amino acids for veterinary
purposes; protein supplements for animals; bacterial
preparations for veterinary purposes; herbal detoxification
agents for animals; mineral dietary supplements for animals;
nutritional supplements for livestock feed; food supplements
for farm animals; nutritional supplements for veterinary
use. Animal foodstuffs; mixed animal feed; formula animal feed;
animal feed preparations; yeast for animal fodder.
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Dietary supplements for animals; medicated feed additives
for animals; medicated supplements for foodstuffs for
animals; feed supplements for veterinary use; feeding
stimulants for animals; medicated animal feed; medicated
additives for animal foods; probiotic supplements for
animals; enzymes for veterinary purposes; enzyme dietary
supplements for animals; amino acids for veterinary
purposes; protein supplements for animals; bacterial
preparations for veterinary purposes; herbal detoxification
agents for animals; mineral dietary supplements for animals;
nutritional supplements for livestock feed; food supplements
for farm animals; nutritional supplements for veterinary
use. Animal foodstuffs; mixed animal feed; formula animal feed;
animal feed preparations; yeast for animal fodder.
The present invention relates to emulsions containing at least one sunscreen active agent and having improved sun protection factor (SPF) properties, as well as methods of improving sun protection factor (SPF) properties.
An isolated and/or recombinant polypeptide, wherein the polypeptide has an amino acid sequence which, when aligned with the amino acid sequence set out in SEQ ID NO: 2, comprises at least one substitution of the amino acid residue corresponding to the amino acid in position 50, 295 or 321, wherein said positions are defined with reference to SEQ ID NO: 2.
C12P 19/18 - Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
A23C 9/12 - Fermented milk preparationsTreatment using microorganisms or enzymes
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Hydrocolloids, gelling agents, thickening agents, stabilizers, emulsifiers, binding agents, gums, modified starches, pectins and fibers for use in the manufacture of food and beverage products, pharmaceuticals, personal care products and cosmetics.
The present invention relates to a process and an apparatus for cultivating a microorganism with pure oxygen in a fermenter. At least part of the gas leaving the headspace of the fermenter is recirculated into the fermentation broth. A gas containing at least 30% oxygen in volume is added to the recirculated gas.
The invention relates to a method and system for supplying drinking water with added methane reducer to animals, where a concentration of the methane reducer is measured and the amount of methane reducer that is added to the water is adjusted based on the measured concentration.
The present invention relates to a formulation, which comprises a fat-soluble vitamin and which can be used for fortifying food products (especially staple food).
The present invention provides a method for generating nitrite and/or nitrate ions from a nitrate ester and a method for detecting nitrate esters in a mixture by generating and detecting nitrite and/or nitrate ions.
G01N 31/22 - Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroupsApparatus specially adapted for such methods using chemical indicators
Disclosed herein is a composition that contains a polyhexamethylene guanidine salt and a thermoplastic polymer. The polyhexamethylene guanidine salt is grafted to the thermoplastic polymer. The present invention also relates to a method of forming the composition and to a mixture that can be beneficially employed to form the composition. The present invention also relates to medical devices comprising or consisting of said composition or from said mixture.
A combination of antioxidants which are delivered to the gut microbiome provides a degree of improbment to gut health comparable to known prebiotics, such as soluble fibers. The antioxidants are riboflavin, beta-carotene, Vitamin C and Vitamin E.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Chemicals and biochemicals for use in industry, namely, for
use in agriculture, except fungicides, herbicides,
insecticides and parasiticides; chemical and biochemical
products for use in the manufacture of animal food; chemical
and biochemical products for use in the manufacture of
fodder; additives to fodder, namely, animal fodder additives
for use in manufacturing animal feed and animal fodder. Veterinary products; chemical preparations for veterinary
use; additives for food for animals for medical use;
additives for fodder, for medical use; additives to fodder,
namely, additives in the nature of dietary supplements for
animals; nutritional additives for food for animals, not for
medical use. Food for animals; foodstuffs for animals; animal fattening
preparations.
